|
Volumn 13, Issue 6, 2000, Pages 20-24
|
Expensive pipeline therapies under attack
a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTIDIABETIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTINEOPLASTIC AGENT;
HORMONE;
HYPOCHOLESTEROLEMIC AGENT;
BIOTECHNOLOGY;
BUDGET;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
ECONOMIC ASPECT;
FINANCIAL MANAGEMENT;
HEALTH CARE COST;
HUMAN;
LAW;
NATIONAL HEALTH INSURANCE;
PHARMACY;
REVIEW;
UNITED STATES;
|
EID: 0033843337
PISSN: 10408304
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (1)
|